Dexi Wu

NHC Key Laboratory Of Assisted Circulation And Vascular Disease
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Cardiovascular Outcomes and Variability in Plasma Lipid Levels Across Body Mass Index Categories: The ARIC Study.

Cardiovascular Outcomes and Variability in Plasma Lipid Levels Across Body Mass Index Categories: The ARIC Study.

Journal: Journal of nutrition and metabolism

Published: January 31, 2025

Reappraisal of ANK2 Variants in Cardiovascular Diseases: Uncovering Mechanisms and Future Directions.

Reappraisal of ANK2 Variants in Cardiovascular Diseases: Uncovering Mechanisms and Future Directions.

Journal: Reviews in cardiovascular medicine

Published: August 05, 2024

The use of non-vitamin K antagonist oral anticoagulants in chronic thromboembolic pulmonary hypertension: an updated meta-analysis.

The use of non-vitamin K antagonist oral anticoagulants in chronic thromboembolic pulmonary hypertension: an updated meta-analysis.

Journal: Journal of thrombosis and thrombolysis

Published: July 09, 2024

Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis.

Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis.

Journal: International journal of cardiology. Heart & vasculature

Published: July 03, 2024

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction.

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction.

Journal: ESC heart failure

Published: December 26, 2020

Prognostic Implication of Liver Function Tests in Heart Failure With Preserved Ejection Fraction Without Chronic Hepatic Diseases: Insight From TOPCAT Trial.

Prognostic Implication of Liver Function Tests in Heart Failure With Preserved Ejection Fraction Without Chronic Hepatic Diseases: Insight From TOPCAT Trial.

Journal: Frontiers in cardiovascular medicine

Published: October 18, 2020

C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial.

C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial.

Journal: BMC medicine

Published: September 11, 2020

Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.

Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.

Journal: ESC heart failure

Published: July 10, 2020

Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study.

Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study.

Journal: BMJ open

Published: May 20, 2020

Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT.

Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT.

Journal: ESC heart failure

Published: April 19, 2020

Prognostic Value of Cysteine-Rich Protein 61 Combined with N-Terminal Pro-B-Type Natriuretic Peptide for Mortality in Acute Heart Failure Patients with and without Chronic Kidney Disease.

Prognostic Value of Cysteine-Rich Protein 61 Combined with N-Terminal Pro-B-Type Natriuretic Peptide for Mortality in Acute Heart Failure Patients with and without Chronic Kidney Disease.

Journal: Cardiorenal medicine

Published: May 20, 2019

Prognostic Significance of Serum Cysteine-Rich Protein 61 in Patients with Acute Heart Failure.

Prognostic Significance of Serum Cysteine-Rich Protein 61 in Patients with Acute Heart Failure.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: October 04, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026